FACTANKER
Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
Value
{"unit": "CHF", "value": 45881}
Period
2020-01-01 – 2020-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-018959
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/02b3aa2e-5398-4c07-baa6-653401b4b2ec
History
no predecessors — first report